Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | June 2020

Roundtable Discussion: Percutaneous AV Fistulae: What to Expect in the Learning Curve

Perspectives on patient candidacy, technical challenges and follow-up protocols, considerations for cannulation, and steps for handling inadequate flow.

With Bart Dolmatch, MD; Alexandros Mallios, MD; Neghae Mawla, MD; Tobias Steinke, MD; and Allison Tan, MD

evt | News | July 21, 2020

Avenu Medical’s Ellipsys Vascular Access System Evaluated for Percutaneous AVF Creation

July 21, 2020—Avenu Medical, Inc. announced that findings from a study of the company’s Ellipsys vascular access system were published by Alexandros Mallios, MD, et al online in Journal of Vascular Surgery.

Sponsored by Contego Medical, Inc.

evt | Article | October 2025 Supplement

Advancing Stroke Protection in Carotid Stenting With Integrated Embolic Protection (IEP™) Technology

evt | News | November 14, 2018

Avenu Medical Introduces Ellipsys Fistula Creation System, Receives CMS Reimbursement Code

November 15, 2018—Avenu Medical, Inc.'s FDA-approved Ellipsys vascular access system was introduced at CiDA, the Controversies in Dialysis Access meeting held November 1–2 in Washington, DC.

Advertisement

evt | Article | June 2020

Maintaining Progress in Challenging Times

By Bart Dolmatch, MD, and Stephen E. Hohmann, MD, FACS

evt | News | September 10, 2020

Study Compares Avenu Ellipsys Access System and BD WavelinQ for pAVF Creation

September 10, 2020—Avenu Medical announced the publication of a study comparing the company’s Ellipsys vascular access system and the WavelinQ 4-F system (BD Interventional) for percutaneous arteriovenous fistula (pAVF) in patients with end-stage renal disease.

Sponsored by BD

evt | Article | October 2019 Supplement

How Do You Utilize Your Network Partners Cohesively to Successfully Create an EndoAVF Program?

Experience-based insights of initiation and adoption of endoAVF creation using the WAVELINQ™ EndoAVF System.

With Alejandro Alvarez, MD; Aurang Z. Khawaja, MD; and George L. Mueller, MD

evt | Article | June 2021

Panel Discussion: Percutaneous AV Fistulas: Where Do We Stand?

Experts discuss what the availability of pAVFs has meant for practice, patient selection, outcomes of pAVF versus surgical fistulas, cannulation after pAVF creation, and referral successes and challenges.

With Alejandro Alvarez, MD; Neghae Mawla, MD; Robert Shahverdyan, MD; and Allison Tan, MD

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button